The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi-institution teams to advance their groundbreaking cancer research projects. The grants will support studies on mechanisms that... Read more
Scientists in recent years have found that tumor cells biopsied from cancer patients can be grown in the lab into specialized tissues called organoids that mimic many aspects of the organ from which they are derived. Now... Read more
Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, Research Reveals Why Some Tumors Have Different Makeup of Cells , which was published in Developmental Cell. Molecular... Read more
Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative. Lewis Cantley, Ph.D. Named 2020 Award Winner for the... Read more
Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression , which was... Read more
#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K " If I get a result that suddenly doesn't make sense, to me that's more exciting. . .if you figure out why it didn't work and what was... Read more
Gene mutations that are thought to be very early events in the development of leukemias and other blood disorders appear to set the stage for malignancy by increasing the production of certain types of blood cells at the... Read more
The scope of the DNA changes that drive cancers has been illuminated as never before in a set of studies by a large international scientific team including Weill Cornell Medicine researchers. In six studies published Feb. 5... Read more
A change in the protein composition of chromatin—the condensed, packaged form of DNA in the nucleus—boosts the expression of metastasis-related genes; blocking this change appears to stop tumor cells from forming new tumors... Read more
Weill Cornell Medicine has received a prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network (IOTN) to explore the mechanisms that allow slow-growing lung cancer lesions... Read more
Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more
Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine, and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more
Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and... Read more
Dr. Gina Lee , a former postdoctoral fellow in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine who has now joined the institution’s faculty, has won a 2019 Tri-Institutional Breakout Award for Junior... Read more
A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better... Read more
NewYork-Presbyterian's Health Matters' Amazing Things: Ronda Kotelchuck When Ronda Kotelchuck learned she had an aggressive form of uterine cancer, she was frightened and anxious about the road ahead. Within a week of her... Read more
Steven Lipkin, M.D., Ph.D., Co-Leader of the Meyer Cancer Center's Cancer Genetics, Epigenetics, and Systems Biology Program, reported results of a cancer prevention vaccine at the American Association for Cancer Research... Read more
Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. The study ,... Read more
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named Chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at... Read more
Early-career scientist Wendy Béguelin, PhD, has been named a NextGen Star by the American Association for Cancer Research (AACR). The AACR's NextGen Star Program provides an exciting opportunity to increase the visibility of... Read more
